This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, University System of Maryland. Active years: 2019-2025.
Company Filing History:
3 out of 3,690 
3 out of 2,023 
Years Active: 2019-2025
Title: The Innovative Contributions of Wen Qing Li
Introduction
Wen Qing Li is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of medical research, particularly in the development of antibodies for cancer treatment. With a total of 3 patents, his work has the potential to impact the lives of many patients suffering from acute lymphoblastic leukemia.
Latest Patents
One of Wen Qing Li's latest patents involves IL-7R-alpha specific antibodies for treating acute lymphoblastic leukemia. This patent discloses antibodies and antigen binding fragments that specifically bind to IL-7Rα. Additionally, it provides nucleic acids encoding these antibodies and antigen binding fragments, along with vectors that include the nucleic acid molecules. The patent also outlines methods for detecting cancer or cells that express IL-7Rα using these antibodies and fragments. Furthermore, it describes the use of these antibodies and fragments to prevent and/or treat subjects with cancers that express IL-7Rα, such as acute lymphoblastic leukemia.
Career Highlights
Wen Qing Li has worked with prominent organizations, including the Department of Health and Human Services, representing the United States of America, and the University System of Maryland. His work in these institutions has allowed him to contribute to significant advancements in medical research and innovation.
Collaborations
Wen Qing Li has collaborated with notable colleagues, including Scott Durum and Julie Hixon. Their combined expertise has fostered an environment of innovation and discovery in the field of cancer research.
Conclusion
Wen Qing Li's contributions to the field of medical research, particularly through his patents on IL-7R-alpha specific antibodies, highlight his commitment to advancing cancer treatment. His collaborations and career achievements further underscore his role as a significant inventor in the medical community.